Citas bibligráficas
Santos, G., (2003). Cardioversión química temprana en fibrilación auricular: Hospital Militar Central (enero 2000-junio 2002) [Tesis de segunda especialidad, Universidad Nacional Mayor de San Marcos]. https://hdl.handle.net/20.500.12672/1919
Santos, G., Cardioversión química temprana en fibrilación auricular: Hospital Militar Central (enero 2000-junio 2002) [Tesis de segunda especialidad]. PE: Universidad Nacional Mayor de San Marcos; 2003. https://hdl.handle.net/20.500.12672/1919
@misc{renati/481330,
title = "Cardioversión química temprana en fibrilación auricular: Hospital Militar Central (enero 2000-junio 2002)",
author = "Santos Carrasco, Gina",
publisher = "Universidad Nacional Mayor de San Marcos",
year = "2003"
}
--- Atrial Fibrilation is a frequent arrhytmia. A therapeutic option for this pathology is quimic cardioversion. The objective of this study was to investigate the efficacy of intravenous amiodarona in recent onset atrial fibrilation. We studied 40 patients who where admitted to the emergency department with diagnostic of recent onset atrial fibrillation who recibed intravenous amiodarone. Quimic cardioversion was achieved in 87.5% of them, with good tolerance and side effects presenting in 10 % of the patients. Conclusion: the precocious therapy with intravenous amiodarona as a quimic cardiovertor is effective and well tolerated. Amiodarone is well tolerated as a precocious treatment for quimic cardioversion in patients with atrial fibrillation.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons